quinoline compounds (TB Alliance/DNDi/CDRI/Advinus Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namequinoline compounds (TB Alliance/DNDi/CDRI/Advinus Therapeutics)
Drug Alias NameSCYX-2035811
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide donors
TargetsUpdating
Therapy Area/IndicationsLeishmania donovani infectionChagas DiseaseTrypanosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwitzerlandIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTb Alliance
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEurofins Advinus LtdCentral Drug Research InstituteDrugs For Neglected Diseases Initiative +[4] 
Active IndicationsN/A
Inactive IndicationsLeishmania donovani infectionChagas DiseaseTrypanosomiasis

Other Information

ATC CodeN/A
Related LinksN/A